SPECTOR STEVEN W 4
4 · ARENA PHARMACEUTICALS INC · Filed Feb 14, 2020
Insider Transaction Report
Form 4
SPECTOR STEVEN W
SVP, General Counsel & Sec
Transactions
- Exercise/Conversion
Common Stock
2020-02-13$32.50/sh+2,472$80,340→ 15,339 total - Exercise/Conversion
Common Stock
2020-02-13$37.20/sh+4,964$184,661→ 20,303 total - Sale
Common Stock
2020-02-13$55.00/sh−10,836$595,980→ 9,467 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-02-13−2,472→ 1,254 totalExercise: $32.50Exp: 2020-03-17→ Common Stock (2,472 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-02-13−4,964→ 2,536 totalExercise: $37.20Exp: 2021-12-15→ Common Stock (4,964 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
- [F2]The options vested in four equal annual installments (except as otherwise necessary to avoid vesting of a fractional share) beginning on March 17, 2011, and ending on March 17, 2014, and became exercisable once vested.
- [F3]The options vested in four equal annual installments (except as otherwise necessary to avoid vesting of a fractional share) beginning on December 15, 2015, and ending on December 15, 2018, and became exercisable once vested.